Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does LEVOLEUCOVORIN Cause Peripheral arterial occlusive disease? 7 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 7 reports of Peripheral arterial occlusive disease have been filed in association with LEVOLEUCOVORIN (Levoleucovorin). This represents 0.2% of all adverse event reports for LEVOLEUCOVORIN.

7
Reports of Peripheral arterial occlusive disease with LEVOLEUCOVORIN
0.2%
of all LEVOLEUCOVORIN reports
0
Deaths
0
Hospitalizations

How Dangerous Is Peripheral arterial occlusive disease From LEVOLEUCOVORIN?

Of the 7 reports.

Is Peripheral arterial occlusive disease Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for LEVOLEUCOVORIN. However, 7 reports have been filed with the FAERS database.

What Other Side Effects Does LEVOLEUCOVORIN Cause?

Diarrhoea (302) Nausea (274) Neutropenia (246) Decreased appetite (223) Neuropathy peripheral (178) Neutrophil count decreased (176) Pyrexia (175) Vomiting (167) Febrile neutropenia (130) Off label use (125)

What Other Drugs Cause Peripheral arterial occlusive disease?

NILOTINIB (319) METHOTREXATE (120) ADALIMUMAB (116) RIVAROXABAN (101) PONATINIB (90) IMATINIB (86) ASPIRIN (77) ATORVASTATIN (70) METOPROLOL (70) CALCIUM\DEXTROSE\MAGNESIUM\SODIUM\SODIUM (63)

Which LEVOLEUCOVORIN Alternatives Have Lower Peripheral arterial occlusive disease Risk?

LEVOLEUCOVORIN vs LEVOMEPROMAZINE LEVOLEUCOVORIN vs LEVOMETHADONE LEVOLEUCOVORIN vs LEVOMILNACIPRAN LEVOLEUCOVORIN vs LEVONORGESTREL LEVOLEUCOVORIN vs LEVORPHANOL

Related Pages

LEVOLEUCOVORIN Full Profile All Peripheral arterial occlusive disease Reports All Drugs Causing Peripheral arterial occlusive disease LEVOLEUCOVORIN Demographics